Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chaihu Shugan Wan is a traditional Chinese medicine (TCM) product manufactured by Liaoning Jindan Pharmaceutical. It is a classic herbal formula primarily used to soothe the liver, regulate qi circulation, and alleviate pain. The formulation typically consists of several herbal ingredients, including Bupleurum chinense (Chaihu), Citrus reticulata (Chenpi), Ligusticum chuanxiong (Chuanxiong), Cyperus rotundus (Xiangfu), Citrus aurantium (Zhiqiao), Paeonia lactiflora (Shaoyao), and Glycyrrhiza uralensis (Gancao). It is indicated for conditions associated with liver qi stagnation, such as chest and hypochondriac distension, emotional distress, and digestive discomfort. In the context of Liaoning Jindan Pharmaceutical, it is an approved and marketed product in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chaihu shugan wan.